Merck FDA Accepts ENFLONSIA sBLA for Second RSV Season
RAHWAY, N.J., August 6, 2026 Merck announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental...
Immunization
Advertisement
Pfizer and BioNTech Win EU Approval for XFG COVID-19 Vaccine
NEW YORK and MAINZ, Germany, July 29, 2026 Pfizer Inc. and BioNTech SE announced that the European Commission (EC)...
Bavarian Nordic Seeks Brazil Approval for Chikungunya Vaccine
COPENHAGEN, Denmark, July 13, 2026 Bavarian Nordic announced that its Brazilian partner Eurofarma has submitted a marketing authorization application...
Merck’s CAPVAXIVE Wins FDA Approval for High-Risk Children
RAHWAY, N.J., June 18, 2026 Merck announced that the U.S. Food and Drug Administration (FDA) has approved an expanded...
Şahin and Türeci Honored for Vaccine Innovation
WASHINGTON, May 13, 2026 The Sabin Vaccine Institute honored renowned vaccine researchers Professor Uğur Şahin and Professor Özlem Türeci...
Advertisements
Pfizer and BioNTech Report Strong Data for LP.8.1-Adapted COVID-19 Vaccine
NEW YORK & MAINZ, Germany – September 8, 2025 – Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX)...
Merck’s CAPVAXIVE Shows Strong Immune Response in Children
RAHWAY, N.J. – September 11, 2025 – Merck (NYSE: MRK), known as MSD outside the United States and Canada,...
Advertisement
